Metselaar JM - Search Results

1

A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis.

Alaarg A, Senders ML, Varela-Moreira A, Pérez-Medina C, Zhao Y, Tang J, Fay F, Reiner T, Fayad ZA, Hennink WE, Metselaar JM, Mulder WJM, Storm G. Alaarg A, et al. Among authors: metselaar jm. J Control Release. 2017 Sep 28;262:47-57. doi: 10.1016/j.jconrel.2017.07.013. Epub 2017 Jul 9. J Control Release. 2017. PMID: 28700897 Free article.

2

Pharmacokinetic modeling of the in vivo fate of long-circulating liposomes in rats.

Hrynyk R, Metselaar JM, Storm G, Langner M. Hrynyk R, et al. Among authors: metselaar jm. Cell Mol Biol Lett. 2002;7(2):285. Cell Mol Biol Lett. 2002. PMID: 12097956 No abstract available.

3

Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis.

Metselaar JM, Wauben MH, Boerman OC, Van Lent PL, Storm G. Metselaar JM, et al. Cell Mol Biol Lett. 2002;7(2):291-2. Cell Mol Biol Lett. 2002. PMID: 12097962 No abstract available.

4

Liposomes for intravenous drug targeting: design and applications.

Metselaar JM, Mastrobattista E, Storm G. Metselaar JM, et al. Mini Rev Med Chem. 2002 Aug;2(4):319-29. doi: 10.2174/1389557023405873. Mini Rev Med Chem. 2002. PMID: 12370053 Review.

5

Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.

Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, Boerman OC, Storm G. Metselaar JM, et al. Arthritis Rheum. 2003 Jul;48(7):2059-66. doi: 10.1002/art.11140. Arthritis Rheum. 2003. PMID: 12847701 Free article.

6

A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.

Metselaar JM, Bruin P, de Boer LW, de Vringer T, Snel C, Oussoren C, Wauben MH, Crommelin DJ, Storm G, Hennink WE. Metselaar JM, et al. Bioconjug Chem. 2003 Nov-Dec;14(6):1156-64. doi: 10.1021/bc0340363. Bioconjug Chem. 2003. PMID: 14624629

7

Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis.

Metselaar JM, van den Berg WB, Holthuysen AE, Wauben MH, Storm G, van Lent PL. Metselaar JM, et al. Ann Rheum Dis. 2004 Apr;63(4):348-53. doi: 10.1136/ard.2003.009944. Ann Rheum Dis. 2004. PMID: 15020326 Free PMC article.

8

Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.

Schiffelers RM, Metselaar JM, Fens MH, Janssen AP, Molema G, Storm G. Schiffelers RM, et al. Among authors: metselaar jm. Neoplasia. 2005 Feb;7(2):118-27. doi: 10.1593/neo.04340. Neoplasia. 2005. PMID: 15802017 Free PMC article.

9

Enzymatic degradation of liposome-grafted poly(hydroxyethyl L-glutamine).

Romberg B, Metselaar JM, deVringer T, Motonaga K, Kettenes-van den Bosch JJ, Oussoren C, Storm G, Hennink WE. Romberg B, et al. Among authors: metselaar jm. Bioconjug Chem. 2005 Jul-Aug;16(4):767-74. doi: 10.1021/bc0497719. Bioconjug Chem. 2005. PMID: 16029017

10

Liposomes in the treatment of inflammatory disorders.

Metselaar JM, Storm G. Metselaar JM, et al. Expert Opin Drug Deliv. 2005 May;2(3):465-76. doi: 10.1517/17425247.2.3.465. Expert Opin Drug Deliv. 2005. PMID: 16296768 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters